or-bot with headset 1
Ocutrx’s Oculenz Advances from AR Headset to Full Surgery Visualization Theatre
May 14, 2020 08:00 ET | Ocutrx Vision Technologies, LLC
IRVINE, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- The maker of breakthrough augmented-extended reality (AR/XR) glasses that provide a radically new surgical viewing experience for retinal surgeons...
logo color s and clearside.jpg
Clearside Biomedical Announces First Quarter 2020 Financial Results
May 08, 2020 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., May 08, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
logo_ProQR-150x150.png
ProQR Announces First Quarter 2020 Operating and Financial Results
May 07, 2020 07:00 ET | ProQR Therapeutics N.V.
Reported positive interim analysis findings from Phase 1/2 Stellar trial of QR-421a for Usher syndrome and non-syndromic retinitis pigmentosa – study ongoing with dose expansion and escalation...
logo color s and clearside.jpg
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
April 28, 2020 07:05 ET | Clearside Biomedical, Inc.
- Management to Host Webcast and Conference Call Today at 8:30 A.M. ET - ALPHARETTA, Ga., April 28, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company...
Dr. Linda Lam
Ocutrx Executive to Lead Augmented Reality Session in Global E-Conference on Ophthalmology
April 22, 2020 09:00 ET | Ocutrx Vision Technologies, LLC
IRVINE, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC, an advanced research and development manufacturer of Augmented Reality (AR) glasses, is pleased to announce that...
Nancy Hutson Photo
Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors
April 22, 2020 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., April 22, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
graybug.jpg
Nature Communications Highlights Research by Scientists at Graybug Vision and Johns Hopkins University on Sustained Treatment of Retinal Diseases
April 21, 2020 07:30 ET | Graybug Vision, Inc.
REDWOOD CITY, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat vision-threatening...
logo color s and clearside.jpg
Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians
April 09, 2020 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., April 09, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Cross Keys Capital Advises Lehigh Valley Eye Center and Valley Eye Surgical Center on Their Partnership with Spectrum Vision Partners
March 31, 2020 19:32 ET | Cross Keys Capital, LLC.
Fort Lauderdale, FL, March 31, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Lehigh Valley Eye Center, PC ("LVEC") and SLTLBK Associates, LLC dba Valley Eye...
logo_ProQR-150x150.png
ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update
March 31, 2020 06:00 ET | ProQR Therapeutics N.V.
QR-421a showed early and encouraging evidence of activity, with 25% of patients showing a benefit across multiple concordant outcome measures and was well tolerated with no serious adverse...